385 related articles for article (PubMed ID: 20503973)
1. Regioselective synthesis and in vitro anticancer activity of 4-aza-podophyllotoxin derivatives catalyzed by L-proline.
Shi C; Wang J; Chen H; Shi D
J Comb Chem; 2010 Jul; 12(4):430-4. PubMed ID: 20503973
[TBL] [Abstract][Full Text] [Related]
2. Facile synthesis of new 4-aza-podophyllotoxin analogs via microwave-assisted multi-component reactions and evaluation of their cytotoxic activity.
Shi F; Zeng XN; Zhang G; Ma N; Jiang B; Tu S
Bioorg Med Chem Lett; 2011 Dec; 21(23):7119-23. PubMed ID: 22004717
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxins as potential anticancer agents.
Reddy PB; Agrawal SK; Singh S; Bhat BA; Saxena AK; Kumar HM; Qazi GN
Chem Biodivers; 2008 Sep; 5(9):1792-802. PubMed ID: 18816530
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
[TBL] [Abstract][Full Text] [Related]
5. Studies on novel 4beta-[(4-substituted)-1,2,3-triazol-1-yl] podophyllotoxins as potential anticancer agents.
Bhat BA; Reddy PB; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
Eur J Med Chem; 2008 Oct; 43(10):2067-72. PubMed ID: 17988764
[TBL] [Abstract][Full Text] [Related]
6. 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation.
Reddy DM; Srinivas J; Chashoo G; Saxena AK; Sampath Kumar HM
Eur J Med Chem; 2011 Jun; 46(6):1983-91. PubMed ID: 21477899
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of 4β-triazole-podophyllotoxin derivatives by azide-alkyne cycloaddition and biological evaluation as potential antitumor agents.
Chen H; Zuo S; Wang X; Tang X; Zhao M; Lu Y; Chen L; Liu J; Liu Y; Liu D; Zhang S; Li T
Eur J Med Chem; 2011 Sep; 46(9):4709-14. PubMed ID: 21821321
[TBL] [Abstract][Full Text] [Related]
8. Development of cobalt(3,4-diarylsalen) complexes as tumor therapeutics.
Gust R; Ott I; Posselt D; Sommer K
J Med Chem; 2004 Nov; 47(24):5837-46. PubMed ID: 15537341
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and cytotoxic activity of novel derivatives of 4'-demethylepipodophyllotoxin.
Chen SW; Tian X; Tu YQ
Bioorg Med Chem Lett; 2004 Oct; 14(20):5063-6. PubMed ID: 15380199
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of new 4beta-anilino- and 4beta-imido-substituted podophyllotoxin congeners.
Kamal A; Gayatri NL; Reddy DR; Mohan Reddy PS; Arifuddin M; Dastidar SG; Kondapi AK; Rajkumar M
Bioorg Med Chem; 2005 Nov; 13(22):6218-25. PubMed ID: 16061385
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and cytotoxic evaluation of C-9 oxidized podophyllotoxin derivatives.
Castro MA; Miguel del Corral JM; Gordaliza M; García PA; Gómez-Zurita MA; San Feliciano A
Bioorg Med Chem; 2007 Feb; 15(4):1670-8. PubMed ID: 17197187
[TBL] [Abstract][Full Text] [Related]
12. Tuned C-H functionalization to construct aza-podophyllotoxin/aza-conidendrin derivatives by means of domino cyclization.
Hu Y; Qu Y; Wu F; Gui J; Wei Y; Hu Q; Wang S
Chem Asian J; 2010 Feb; 5(2):309-14. PubMed ID: 20041457
[TBL] [Abstract][Full Text] [Related]
13. Oxiranylmethyloxy or thiiranylmethyloxy-azaxanthones and -acridone analogues as potential topoisomerase I inhibitors.
Cho HJ; Jung MJ; Kwon Y; Na Y
Bioorg Med Chem Lett; 2009 Dec; 19(23):6766-9. PubMed ID: 19836231
[TBL] [Abstract][Full Text] [Related]
14. Synthesis, biological activity, and quantitative structure-activity relationship study of azanaphthalimide and arylnaphthalimide derivatives.
Braña MF; Gradillas A; Gómez A; Acero N; Llinares F; Muñoz-Mingarro D; Abradelo C; Rey-Stolle F; Yuste M; Campos J; Gallo MA; Espinosa A
J Med Chem; 2004 Apr; 47(9):2236-42. PubMed ID: 15084122
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and in-vitro cytotoxicity evaluation of novel naphtindolizinedione derivatives, part II: improved activity for aza-analogues.
Defant A; Guella G; Mancini I
Arch Pharm (Weinheim); 2009 Feb; 342(2):80-6. PubMed ID: 19173337
[TBL] [Abstract][Full Text] [Related]
16. Discovery and investigation of antiproliferative and apoptosis-inducing properties of new heterocyclic podophyllotoxin analogues accessible by a one-step multicomponent synthesis.
Magedov IV; Manpadi M; Slambrouck SV; Steelant WF; Rozhkova E; Przheval'skii NM; Rogelj S; Kornienko A
J Med Chem; 2007 Oct; 50(21):5183-92. PubMed ID: 17894480
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor evaluation of bis aza-anthracene-9,10-diones and bis aza-anthrapyrazole-6-ones.
Antonini I; Santoni G; Lucciarini R; Amantini C; Dal Ben D; Volpini R; Cristalli G
J Med Chem; 2008 Feb; 51(4):997-1006. PubMed ID: 18232651
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of a new 4-aza-2,3-didehydropodophyllotoxin analogues as potent cytotoxic and antimitotic agents.
Kamal A; Suresh P; Mallareddy A; Kumar BA; Reddy PV; Raju P; Tamboli JR; Shaik TB; Jain N; Kalivendi SV
Bioorg Med Chem; 2011 Apr; 19(7):2349-58. PubMed ID: 21402478
[TBL] [Abstract][Full Text] [Related]
19. [4-Aza-2,3-didehydropodophyllotoxins: new lignan with antitumor activity obtained from one-step synthesis].
Giorgi-Renault S
Ann Pharm Fr; 2005 Jan; 63(1):63-8. PubMed ID: 15803102
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationships of novel 1-arylmethyl-3-aryl-1H-pyrazole-5-carbohydrazide derivatives as potential agents against A549 lung cancer cells.
Xia Y; Dong ZW; Zhao BX; Ge X; Meng N; Shin DS; Miao JY
Bioorg Med Chem; 2007 Nov; 15(22):6893-9. PubMed ID: 17804244
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
